Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

AZ shuns mega-mergers but still open to smaller deals

April 21, 2009 Research and Development, Sales and Marketing AZ

AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …
News

Pfizer opens $200m R&D site in St Louis

April 21, 2009 Research and Development Pfizer, US

News

Is the UK falling behind in clinical trials?

April 21, 2009 Research and Development NHS

New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing …
News

GSK buys Stiefel for $3.6bn

April 20, 2009 Research and Development, Sales and Marketing GSK, MA

GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
News

GSK and Pfizer to create HIV joint venture company

April 16, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
News

Merck acquires rights to atrial fibrillation candidate

April 16, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …
News

Simponi approved in Canada

April 16, 2009 Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …
News

Covance expands in Latin America

April 15, 2009 Research and Development Covance, Peru, South America

Covance has opened new clinical development offices in Chile and Peru, and expanded its operations in Argentina to help serve …
News

Helsinn chooses Dublin for R&D investment

April 14, 2009 Research and Development Helsinn

Helsinn Birex Pharmaceuticals is to invest 13 million euros in a new pilot-scale R&D facility in Ireland, to help it …
News

Committee approves limited use of Seroquel in depression

April 9, 2009 Research and Development, Sales and Marketing AZ, Seroquel, US

An FDA advisory committee has concluded that safety concerns mean that Seroquel XR should not be used to treat anxiety, …
News

Efient launched in the UK

April 9, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …
News

2-in-1: Merck and Schering-Plough

April 8, 2009 Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …
Feature

Covance acquires early clinical development business in Switzerland

April 8, 2009 Research and Development Covance

Covance has expanded its presence in clinical pharmacology in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical …
News

Top CROs can look forward to ‘five years of growth’

April 8, 2009 Research and Development CRO

The current economic downturn is having a braking effect on the top 10 contract research organisations, but a new report …
News

Quintiles completes 400th trial using electronic data capture

April 7, 2009 Research and Development CRO, Quintiles

Quintiles has completed its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026